For the interim period of FY March 2027, consolidated net sales were 25,553.9 million yen (YoY +41.2%), operating income was 2,952.0 million yen (YoY +38.9%), ordinary income was 3,006.0 million yen, and net income attributable to owners of the parent for the interim period was 2,082.0 million yen. The Wire & Processed Products segment performed well; Electronics & Medical Components saw lower sales overall but medical components increased. Full-year forecasts remain unchanged.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5821","jir_company_name":"Hirakawa Hewtech Corp.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/5821-20261104-01.pdf","jir_short_summary":"For the interim period of FY March 2027, consolidated net sales were 25,553.9 million yen (YoY +41.2%), operating income was 2,952.0 million yen (YoY +38.9%), ordinary income was 3,006.0 million yen, and net income attributable to owners of the parent for the interim period was 2,082.0 million yen. The Wire & Processed Products segment performed well; Electronics & Medical Components saw lower sales overall but medical components increased. Full-year forecasts remain unchanged.","jir_summary":"### Overview of Results\nHirakawa Hewtech Corp.'s consolidated results for the second quarter (interim) of the fiscal year ending March 2027 were: net sales 25,553.9 million yen, operating income 2,952.0 million yen, ordinary income 3,006.0 million yen, and net income attributable to owners of the parent 2,082.0 million yen. Net sales increased significantly year-on-year, driven by strength in the core Wire & Processed Products business. The Electronics & Medical Components segment recorded lower sales overall due to a decline in electronics, but medical components experienced growth. Earnings levels improved steadily on the whole. Supplementary materials and an earnings presentation are scheduled.\n\n### Outlook and Segment Trends\nBy segment, Wire & Processed Products expanded sales supported by contributions from newly mass-produced products and favorable demand in North America. Electronics & Medical Components saw a decline due to the year-on-year reaction from a large OEM project in the prior period, but the medical components field is in a growth phase. The full-year earnings forecast remains as initially published, with exchange rate movements and the progress of new projects potentially affecting results. Financial position remains healthy with total assets of 59,195 million yen and a shareholders' equity ratio of 75.6%.","jir_financial_highlights":"Net Sales: 25,553.9 million yen (Year-over-Year +41.2%)\nOperating Income: 2,952.0 million yen (Year-over-Year +38.9%)\nOrdinary Income: 3,006.0 million yen (Year-over-Year +48.0%)\nNet Income Attributable to Owners of Parent (Interim): 2,082.0 million yen (Year-over-Year +15.4%)","jir_category":"","jir_hashtags":"#HirakawaHewtech, #Earnings","jir_key_figures":"Net Sales: 25,553.9 million yen (Year-over-Year +41.2%)\nOperating Income: 2,952.0 million yen (Year-over-Year +38.9%)\nNet Income Attributable to Owners of Parent (Interim): 2,082.0 million yen (Year-over-Year +15.4%)","jir_meta_title":"Hirakawa Hewtech Corp. Interim Results FY Mar 2027 | Net Sales Over 25.5 billion yen, Profits Solid","jir_meta_description":"Summary of Hirakawa Hewtech Corp.'s second quarter (interim) results for FY March 2027: net sales up 41.2% YoY and operating income up 38.9%. Explains segment trends and full-year outlook. Includes information on the upcoming earnings presentation.","jir_og_title":"Hirakawa Hewtech Corp. Interim Results FY Mar 2027 | Net Sales Over 25.5 billion yen, Profits Solid","jir_og_description":"Hirakawa Hewtech Corp.'s interim results show a substantial increase in net sales with favorable segment performance. Full-year forecasts unchanged; earnings presentation scheduled.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17426,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-141166","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n